Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133570) titled 'A prospective, single-center, exploratory clinical study of sotrocumab in combination with zanubrutinib for patients with chronic lymphocytic leukemia (CLL) who have received zanubrutinib monotherapy for >= 1 year' on Sept. 29.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Condition:
Chronic Lymphocytic Leukemia
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-30
Target Sample Size: Experimental group:25;
Countries of Recruitment:
China
To know more, visi...